Publications by authors named "Nancy B Davis"

Claim this Profile
E
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study.
Tanya Jindal, Cindy Y Jiang, Omar Alhalabi, Matthew Davidsohn, Dory Freeman, Nancy B Davis

Urol Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, Dimitra Rafailia Bakaloudi, Rafee Talukder, Nancy B Davis

Oncologist· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.
Amanda Nizam, Charles B Nguyen, Jinju Li, Emily C Zabor, Pavlos Msaouel, Nancy B Davis

Cancer Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.
Tanya Jindal, Cindy Y Jiang, Omar Alhalabi, Charles B Nguyen, Eugene Oh, Nancy B Davis

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data.
Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen, Nancy B Davis

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Bladder preservation options for bladder cancer.
Nancy B Davis, Deepak Kilari, Elizabeth R Kessler, Woodson W Smelser

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
Petros Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Nancy B Davis

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
Talal El Zarif, Amin H Nassar, Gregory R Pond, Tony Zibo Zhuang, Viraj Master, Nancy B Davis

J Natl Cancer Inst· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.
Catherine C Fahey, Caroline A Nebhan, Sally York, Nancy B Davis, Paula J Hurley

Int J Mol Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984.
Joseph W Kim, Rana R McKay, Marc R Radke, Shilin Zhao, Mary-Ellen Taplin, Nancy B Davis

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.
Yu-Wei Chen, Matthew D Tucker, Landon C Brown, Hesham A Yasin, Kristin K Ancell, Nancy B Davis

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Nancy B Davis

Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.
Matthew D Tucker, Landon C Brown, Yu-Wei Chen, Chester Kao, Nathan Hirshman, Nancy B Davis

Biomark Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort study.
Kyle A Dymanus, Mohit Butaney, Diana E Magee, Amanda E Hird, Amy N Luckenbaugh, Nancy B Davis

Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.
Eileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, Aaron R Lim, Ayaka Sugiura, Nancy B Davis

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports.
Matthew D Tucker, Kathryn E Beckermann, Jennifer B Gordetsky, Giovanna A Giannico, Nancy B Davis

Front Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.
Christopher G Wood, James E Ferguson, Joel S Parker, Dominic T Moore, Jennifer G Whisenant, Nancy B Davis

JCI Insight· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Nancy B Davis

J Urol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Moshe C Ornstein, Sumanta K Pal, Laura S Wood, Jackie M Tomer, Brian P Hobbs, Nancy B Davis

Lancet Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline.
Larissa Nekhlyudov, Christina Lacchetti, Nancy B Davis, Thomas Q Garvey, David P Goldstein

J Clin Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.
Mohamed S Ahmed, Steven H Kroft, Nancy B Davis, David M King, Yee Chung Cheng

Leuk Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.
Richard T Lee, Kathleen E Beekman, Maha Hussain, Nancy B Davis, Joseph I Clark

Clin Genitourin Cancer· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the natural history of post-radical prostatectomy incontinence using objective pad test data.
Anna R Smither, Michael L Guralnick, Nancy B Davis, William A See

BMC Urol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinoid tumors.
Russell G Robertson, William J Geiger, Nancy B Davis

Am Fam Physician· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-abdominal desmoid tumor following retroperitoneal lymph node dissection for testicular germ cell tumor.
Eric J Lawatsch, Milton W Datta, Peter Van Tuinen, Gary S Sudakoff, Nancy B Davis

Int J Urol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis